-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M5ELIs+8ZWxiZrZFaMg5WWj5RiT1BfQG8qlKtqHXWyoQNVV+U6SMaxgTcLSPCQMV nANNDo8V3eiCKHN1JGKwAw== 0000898430-98-004320.txt : 19981208 0000898430-98-004320.hdr.sgml : 19981208 ACCESSION NUMBER: 0000898430-98-004320 CONFORMED SUBMISSION TYPE: 424B3 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 19981207 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SYNBIOTICS CORP CENTRAL INDEX KEY: 0000719483 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 953737816 STATE OF INCORPORATION: CA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 424B3 SEC ACT: SEC FILE NUMBER: 333-42763 FILM NUMBER: 98764724 BUSINESS ADDRESS: STREET 1: 11011 VIA FRONTERA CITY: SAN DIEGO STATE: CA ZIP: 92127 BUSINESS PHONE: 6194513771 424B3 1 PROSPECTUS SUPPLEMENT Rule 424(b)(3) Registration No. 333-42763 PROSPECTUS SUPPLEMENT SYNBIOTICS CORPORATION This prospectus supplement is dated December 7, 1998. It relates to the Prospectus, dated December 19, 1997, of Synbiotics Corporation under a registration statement on Form S-8, registration number 333-42763. In September 1998 Synbiotics declared a dividend on each share of Common Stock (including the Shares) outstanding on October 7, 1998. The per-share dividend consisted of one Right to purchase, for $10.00, 1/1000th of a share of Synbiotics' Series A Junior Participating Preferred Stock. The dividend was paid on October 7, 1998 and was part of Synbiotics' implementation of a "poison pill" shareholder rights plan. Until a triggering acquisition-oriented event (as defined in Synbiotics' Rights Agreement), each of the Rights is paired with and will trade inseparably with one share of Synbiotics Common Stock. Accordingly, each of the Shares sold under this Prospectus will include not only a share of Common Stock but also the Right which is paired with it. A complete description of the Rights is included in Synbiotics' registration statement on Form 8-A filed on October 7, 1998, which has been incorporated by reference into this Prospectus. -----END PRIVACY-ENHANCED MESSAGE-----